Back to Authors
A5067340633 | I145311141
Mayo Clinic
Alnylam Pharmaceuticals (United States)
Journal of the American Society of Nephrology | May 18, 2024 | Volume: 34 | Issue: 11S | Pages: 572-572
10.1681/asn.20233411s1572a